Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002639098 | SCV002978874 | uncertain significance | not provided | 2023-01-18 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 5160 of the HMCN1 protein (p.Ala5160Thr). This variant is present in population databases (rs759202617, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with HMCN1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. |
Ambry Genetics | RCV004066644 | SCV003751003 | uncertain significance | not specified | 2021-08-16 | criteria provided, single submitter | clinical testing | The c.15478G>A (p.A5160T) alteration is located in exon 100 (coding exon 100) of the HMCN1 gene. This alteration results from a G to A substitution at nucleotide position 15478, causing the alanine (A) at amino acid position 5160 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003455556 | SCV004180630 | uncertain significance | Age related macular degeneration 1 | 2023-04-11 | criteria provided, single submitter | clinical testing |